Environmental risk assessment of anti-cancer drugs and their transformation products: A focus on their genotoxicity characterization-state of knowledge and short comings.

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Mutation research. Reviews in mutation research

• Publication date

  2014-04-01

• Fields of study

  Medicine, Environmental Science

• Identifiers
  DOI 10.1016/j.mrrev.2014.02.001PMID 24556194
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Identification of phototransformation products of thalidomide and mixture toxicity assessment: an experimental and quantitative structural activity relationships (QSAR) approach.

  2014cited by this paper
• Removal of cytostatic drugs from aquatic environment: a review.

  2013cited by this paper
• Chronic ecotoxic effects to Pseudomonas putida and Vibrio fischeri, and cytostatic and genotoxic effects to the hepatoma cell line (HepG2) of ofloxacin photo(cata)lytically treated solutions.

  2013cited by this paper
• Bacterial mutagenicity screening in the pharmaceutical industry.

  2013cited by this paper
• Predicting concentrations of the cytostatic drugs cyclophosphamide, carboplatin, 5‐fluorouracil, and capecitabine throughout the sewage effluents and surface waters of europe

  2013cited by this paper
• Occurrence, Ecotoxicology, and Treatment of Anticancer Agents as Water Contaminants

  2012cited by this paper
• Modeling and predicting aquatic aerobic biodegradation – a review from a user's perspective

  2012cited by this paper
• Genotoxic effect of ciprofloxacin during photolytic decomposition monitored by the in vitro micronucleus test (MNvit) in HepG2 cells

  2012cited by this paper
• Anticancer drugs in surface waters: what can we say about the occurrence and environmental significance of cytotoxic, cytostatic and endocrine therapy drugs?

  2012cited by this paper
• Approach for detecting mutagenicity of biodegraded and ozonated pharmaceuticals, metabolites and transformation products from a drinking water perspective

  2012cited by this paper
• In situ assessment of genotoxic and mutagenic potential of polluted river water in Channa punctatus and Mystus vittatus

  2012cited by this paper
• How accurate is in vitro prediction of carcinogenicity?

  2011cited by this paper
• Recent advances in environmental risk assessment of transformation products.

  2011cited by this paper
• Micronucleus assay in aquatic animals.

  2011cited by this paper
• A framework for evaluating the contribution of transformation products to chemical persistence in the environment.

  2011cited by this paper
• Transformation products of pharmaceuticals in surface waters and wastewater formed during photolysis and advanced oxidation processes - degradation, elucidation of byproducts and assessment of their biological potency.

  2011cited by this paper
• Occurrence, fate and determination of cytostatic pharmaceuticals in the environment

  2011cited by this paper
• Review of QSAR Models and Software Tools for Predicting of Genotoxicity and Carcinogenicity

  2010cited by this paper
• QSAR-analysis and mixture toxicity as diagnostic tools: Influence of degradation on the toxicity and mode of action of diuron in algae and daphnids.

  2010cited by this paper
• Cyclophosphamide degradation by advanced oxidation processes

  2010cited by this paper
• Ecotoxicity and genotoxicity assessment of cytotoxic antineoplastic drugs and their metabolites.

  2010cited by this paper
• Challenge of high polarity and low concentrations in analysis of cytostatics and metabolites in wastewater by hydrophilic interaction chromatography/tandem mass spectrometry.

  2009cited by this paper
• Pharmaceuticals and Personal Care Products in the Environment Environmental Chemistry ENVIRONMENTAL FOOTPRINT OF PHARMACEUTICALS: THE SIGNIFICANCE OF FACTORS BEYOND DIRECT EXCRETION TO SEWERS

  2009cited by this paper
• Umweltrisikobewertung von Zytostatika

  2009cited by this paper
• Effects of ranitidine and its photoderivatives in the aquatic environment.

  2009cited by this paper
• Flows of Active Pharmaceutical Ingredients Originating from Health Care Practices on a Local, Regional, and Nationwide Level in Germany—Is Hospital Effluent Treatment an Effective Approach for Risk Reduction?

  2008cited by this paper
• Pharma-Ecology: The Occurrence and Fate of Pharmaceuticals and Personal Care Products in the Environment

  2008cited by this paper
• Do cytotoxic chemotherapy drugs discharged into rivers pose a risk to the environment and human health? An overview and UK case study

  2008cited by this paper
• Ecotoxicity and genotoxicity assessment of cytostatic pharmaceuticals

  2007cited by this paper
• Fate of 5-fluorouracil, doxorubicin, epirubicin, and daunorubicin in hospital wastewater and their elimination by activated sludge and treatment in a membrane-bio-reactor system.

  2007cited by this paper
• Genotoxicity assessment in oncology nurses handling anti-neoplastic drugs.

  2007cited by this paper
• Hospital wastewater genotoxicity.

  2006cited by this paper
• A multispecies study to assess the toxic and genotoxic effect of pharmaceuticals: furosemide and its photoproduct.

  2006cited by this paper
• Occurrence and fate of the cytostatic drugs cyclophosphamide and ifosfamide in wastewater and surface waters.

  2006cited by this paper
• Investigation into the ability of the Salmonella umu test to detect DNA damage using antitumor drugs.

  2006cited by this paper
• Simplified protocol for evaluating the genotoxic risk of hospital wastewater

  2006cited by this paper
• Pharmaceuticals in the Environment in Italy: Causes, Occurrence, Effects and Control

  2006cited by this paper
• Ecotoxicity of naproxen and its phototransformation products.

  2005cited by this paper
• Efficacy of Two Wastewater Treatment Plants in Removing Genotoxins

  2005cited by this paper
• Genotoxicological studies in aquatic organisms: an overview.

  2004cited by this paper
• Indirect human exposure to pharmaceuticals via drinking water.

  2003cited by this paper
• A comparison between mouse and fish micronucleus test using cyclophosphamide, mitomycin C and various pesticides.

  2002cited by this paper
• Assessment of genotoxic damage in nurses occupationally exposed to antineoplastics by the analysis of chromosomal aberrations

  2002cited by this paper
• Approval summary for imatinib mesylate capsules in the treatment of chronic myelogenous leukemia.

  2002cited by this paper
• A Human Health Risk Assessment of Pharmaceuticals in the Aquatic Environment

  2002cited by this paper
• Biodegradation of the antineoplastics vindesine, vincristine, and vinblastine and their toxicity against bacteria in the aquatic environment.

  2001cited by this paper
• Biodegradability of some antibiotics, elimination of the genotoxicity and affection of wastewater bacteria in a simple test.

  2000cited by this paper
• Variability in micronucleus induction with different mutagens applied to several species of fish

  2000cited by this paper
• Flow cytometric detection of micronuclei and cell cycle alterations in fish-derived cells after exposure to three model genotoxic agents: mitomycin C, vincristine sulfate and benzo(a)pyrene.

  2000cited by this paper
• Chemical degradation of wastes of antineoplastic agents amsacrine, azathioprine, asparaginase and thiotepa.

  1998cited by this paper
• Cytogenetic consequences after occupational exposure to antineoplastic drugs.

  1998cited by this paper
• Trace enrichment, chromatographic separation and biodegradation of cytostatic compounds in surface water

  1998cited by this paper
• Application of a Finnish mutagenicity model to drinking waters in the U.S.

  1998cited by this paper
• Occurrence, fate and effects of pharmaceutical substances in the environment--a review.

  1998cited by this paper
• Chemical degradation of wastes of antineoplastic agents. 2: Six anthracyclines: idarubicin, doxorubicin, epirubicin, pirarubicin, aclarubicin, and daunorubicin.

  1997cited by this paper
• Biodegradability of the anti-tumour agent ifosfamide and its occurrence in hospital effluents and communal sewage

  1997cited by this paper
• Biodegradation and Toxicity of the Antineoplastics Mitoxantron Hydrochloride and Treosulfane in the Closed Bottle Test (OECD 301 D)

  1997cited by this paper
• Biodegradability of the Anti‐tumour Agents 5‐Fluorouracil, Cytarabine, and Gemcitabine: Impact of the Chemical Structure and Synergistic Toxicity with Hospital Effluent

  1997cited by this paper
• Biological degradation of cyclophosphamide and its occurrence in sewage water.

  1997cited by this paper
• Chemical degradation of wastes of antineoplastic agents

  1997cited by this paper
• Belastung von Krankenhausabwasser mit gefährlichen Stoffen im Sinne § 7a WHG

  1996cited by this paper
• Chemical degradation of wastes of antineoplastic agents: cyclophosphamide, ifosfamide and melphalan

  1996cited by this paper
• Detection of genotoxic activity in native hospital waste water by the umuC test.

  1996cited by this paper
• [Tests of biodegradation of cytostatics cyclophosphamide and ifosfamide using the Closed Bottle Test (OECD 301 D)].

  1996cited by this paper
• Trace analysis of the antineoplastics ifosfamide and cyclophosphamide in sewage water by twostep solid-phase extraction and gas chromatography-mass spectrometry

  1996cited by this paper
• Prüfung des biologischen Abbaus der Zytostatika Cyclophosphamid und Ifosfamid mit dem Closed Bottle Test (OECD 301 D)

  1996cited by this paper
• Fish micronuclei for assessing genotoxicity in water.

  1995cited by this paper
• Anticancer drugs: an underestimated risk or an underutilised resource in mutagenesis?

  1995cited by this paper
• Photolytic destruction and polymeric resin decontamination of aqueous solutions of pharmaceuticals.

  1994cited by this paper
• Biomonitoring of nurses handling antineoplastic drugs.

  1994cited by this paper
• X-ray structural characterization of anhydrous metronidazole benzoate and metronidazole benzoate monohydrate.

  1993cited by this paper
• Degradation and inactivation of antitumor drugs.

  1993cited by this paper
• The Cytotoxics Handbook

  1991cited by this paper
• Cytotoxicity and genotoxicity assays with cultured fish cells: A review.

  1991cited by this paper
• Cytotoxic drugs and the aquatic environment: estimation of bleomycin in river and water samples

  1990cited by this paper
• Degradation and disposal of some antineoplastic drugs.

  1989cited by this paper
• A method for the efficient degradation of melphalan into nonmutagenic products

  1987cited by this paper
• Clinical pharmacokinetics of 5-fluorouracil and its metabolites in plasma, urine, and bile.

  1987cited by this paper
• The fate of pharmaceutical chemicals in the aquatic environment

  1985cited by this paper
• Mutagenic activities of cyclophosphamide (NSC-26271) and its main metabolites in Salmonella typhimurium, human peripheral lymphocytes and Chinese hamster ovary cells.

  1984cited by this paper
• Effect of ozonation on the mutagenicity of carcinogens in aqueous solution.

  1982cited by this paper
• WHO-IARC Monographs on the evaluation of the carcinogenic risk of chemicals to humans. Vol. 26. Some Antineoplastic and Immunosuppressive Agents. 411 Seiten. International Agency for Research on Cancer, Lyon 1981. Preis: 62.- sfrs; 30.- US $

  1982cited by this paper
• Mutagenic, teratogenic and pharmacokinetic properties of cyclophosphamide and some of its deuterated derivatives.

  1982cited by this paper
• Comparison of the mutagenicity and teratogenicity of cyclophosphamide and its active metabolites, 4-hydroxycyclophosphamide, phosphoramide mustard, and acrolein.

  1982cited by this paper
• Nonvolatile mutagens in drinking water: production by chlorination and destruction by sulfite.

  1980cited by this paper
• Mutagenicity in urine of nurses handling cytostatic drugs.

  1979cited by this paper
• Mutagenicity in urine of nurses handling cytostatic drugs.

  1979cited by this paper
• An evaluation of 6 short-term tests for detecting organic chemical carcinogens.

  1978cited by this paper
• Detection of carcinogens as mutagens in the Salmonella/microsome test: assay of 300 chemicals: discussion.

  1976cited by this paper
• Alkylating properties of phosphoramide mustard.

  1976cited by this paper
• Detection of carcinogens as mutagens in the Salmonella/microsome test: assay of 300 chemicals.

  1975cited by this paper
• Clinical pharmacology of cyclophosphamide.

  1973cited by this paper

• EcoDrug PLUS: an advanced database for drug target conservation analysis and environmental risk assessment

  2025cites this paper
• A Review on Cytotoxic Antibiotics: Occurrence in Water Matrices, Degradation by Advanced Oxidation Processes, and By-Product Formation

  2025cites this paper
• Toxicological evaluation of imidazo-based heterocyclic derivatives: In-vitro and in-vivo acute toxicity studies

  2024cites this paper
• Marine Resources Offer New Compounds and Strategies for the Treatment of Skin and Soft Tissue Infections

  2023cites this paper
• An updated overview of MOF@MIP in drug carrier and drug analysis: Construction, application and prospective

  2023cites this paper
• Source, Occurrence, and Risk Assessment of Antineoplastic Medicines in Aquatic Environments: A Comprehensive Review

  2023cites this paper
• Efficient Methotrexate Adsorption on Magnetic-Functionalised UiO-66-NH2: Selectivity, Mechanisms and Recycling

  2023cites this paper
• Development and psychometric evaluation of a questionnaire for assessment of exposure to chemical hazards in operating room nurses

  2023cites this paper
• The interplay between anticancer challenges and the microbial communities from the gut

  2022cites this paper
• Sensitivity of Zebrafish Embryogenesis to Risk of Fotemustine Exposure

  2022cites this paper
• Transformation products of sulfonamides in aquatic systems: Lessons learned from available environmental fate and behaviour data.

  2022cites this paper
• Cyclophosphamide affects eye development and locomotion in zebrafish (Danio rerio).

  2022cites this paper
• Persistence, environmental hazards, and mitigation of pharmaceutically active residual contaminants from water matrices.

  2022cites this paper
• Enhanced degradation mechanism of anticancer drug irinotecan through low-frequency ultrasound assisted reactive electrochemical membrane

  2022cites this paper
• TiO2 based photocatalysis membranes: An efficient strategy for pharmaceutical mineralization.

  2022cites this paper
• Investigation of Amoxicillin and Ciprofloxacin Behaviours in Sequencing Batch Reactor and Their Effects on Chemical Oxygen Demand Removal Efficiencies

  2022cites this paper
• RETRACTED: Environmental Risk Assessment of Dexamethasone Sodium Phosphate and Tocilizumab Mixture in Zebrafish Early Life Stage (Danio rerio)

  2022cites this paper
• Highly dispersed Ag and g-C3N4 quantum dots co-decorated 3D hierarchical Fe3O4 hollow microspheres for solar-light-driven pharmaceutical pollutants degradation in natural water matrix.

  2022cites this paper
• Environmental fate, distribution and state-of-the-art removal of antineoplastic drugs: A comprehensive insight

  2021cites this paper
• Degradation of antineoplastic drug etoposide in aqueous environment by photolysis and photocatalysis. Identification of photocatalytic transformation products and toxicity assessment

  2021cites this paper
• Product identification and toxicity change during oxidation of methotrexate by ferrate and permanganate in water

  2021cites this paper
• The Dark Side of Platinum Based Cytostatic Drugs: From Detection to Removal

  2021cites this paper
• Treatment-driven removal efficiency, product formation, and toxicity evolution of antineoplastic agents: Current status and implications for water safety assessment.

  2021cites this paper
• Occurrence and environmental fate of pharmaceuticals, personal care products and illicit drugs (PPCPIDs) in tropical ecosystems

  2021cites this paper
• Aquatic ecotoxicology of anticancer drugs: A systematic review.

  2021cites this paper
• Performance of a Slurry Photocatalytic Membrane Reactor for the Treatment of Real Secondary Wastewater Effluent Polluted by Anticancer Drugs

  2021cites this paper
• Introducing an effective iron-based catalyst for heterogeneous electro-Fenton removal of Gemcitabine using three-dimensional graphene as cathode

  2021cites this paper
• Insight into the Sorption of 5-Fluorouracil and Methotrexate onto Soil–pH, Ionic Strength, and Co-Contaminant Influence

  2021cites this paper
• Nanohybrids-assisted photocatalytic removal of pharmaceutical pollutants to abate their toxicological effects - A review.

  2021cites this paper
• Fate and Effects of Cytostatic Pharmaceuticals in the Marine Environment

  2020cites this paper
• White-rot fungi-mediated biodegradation of cytostatic drugs - bleomycin and vincristine.

  2020cites this paper
• Degradation of anticancer drug capecitabine in aquatic media by three advanced oxidation processes: Mechanisms, toxicity changes and energy cost evaluation

  2020cites this paper
• Apoptosis-Inducing Active Protein from Marine Clam Donax variabilis on NSCLC Cells

  2020cites this paper
• Environmental Remediation of Antineoplastic Drugs: Present Status, Challenges, and Future Directions

  2020influential citation
• Organic micropollutants in water and sediment from Lake Mälaren, Sweden.

  2020cites this paper
• Considerations for the Use of Mutation as a Regulatory Endpoint in Risk Assessment

  2020cites this paper
• Fate and toxicity of pharmaceuticals in water environment: An insight on their occurrence in South Asia.

  2020cites this paper
• Impact of anticancer chemotherapy on the extension of beta-lactamase spectrum: an example with KPC-type carbapenemase activity towards ceftazidime-avibactam

  2020cites this paper
• Fate and Effects of Anticancer Drugs in the Environment

  2020cites this paper
• Elucidation of S-Allylcysteine Role in Inducing Apoptosis by Inhibiting PD-L1 Expression in Human Lung Cancer Cells.

  2020cites this paper
• Genotoxicity of the Residues of Anticancer Drugs: A Hazard for Aquatic Environment

  2020cites this paper
• Cytotoxic responses of the anticancer drug cyclophosphamide in the mussel Mytilus galloprovincialis and comparative sensitivity with human cells lines.

  2020cites this paper
• Analytical Methodologies for the Determination of Cytostatic Compounds in Environmental Matrices

  2020cites this paper
• Degradation and Elimination of Anticancer Drugs by Water and Wastewater Treatment – Toxicity and Biodegradability Before and After the Treatment

  2020cites this paper
• Photocatalysis Using UV-A and UV-C Light Sources for Advanced Oxidation of Anti-Cancer Drugs Spiked in Laboratory-Grade Water and Synthetic Urine

  2020cites this paper
• Effects of mixtures of anticancer drugs in the benthic polychaete Nereis diversicolor.

  2019cites this paper
• Evaluation of genotoxic potential of avarol, avarone, and its methoxy and methylamino derivatives in prokaryotic and eukaryotic test models

  2019cites this paper
• Reducing aquatic micropollutants - Increasing the focus on input prevention and integrated emission management.

  2019cites this paper
• Imatinib: Major photocatalytic degradation pathways in aqueous media and the relative toxicity of its transformation products.

  2019cites this paper
• Do Amazon turtles exposed to environmental concentrations of the antineoplastic drug cyclophosphamide present mutagenic damages? If so, would such damages be reversible?

  2019cites this paper
• A comparative study on the photo-catalytic degradation of Cytarabine anticancer drug under Fe3+/H2O2, Fe3+/S2O82−, and [Fe(C2O4)3]3−/H2O2 processes. Kinetics, identification, and in silico toxicity assessment of generated transformation products

  2019cites this paper
• Ecotoxicity risk of presence of two cytostatic drugs: Bleomycin and vincristine and their binary mixture in aquatic environment.

  2019cites this paper
• Simultaneous and systematic analysis of cytostatic drugs in wastewater samples by ultra-high performance liquid chromatography tandem mass spectrometry.

  2019cites this paper
• Cumulative effects of municipal effluent and parasite infection in yellow perch: A field study using high-throughput RNA-sequencing.

  2019cites this paper
• Genotoxicity Assessment of the Hospital Wastewaters in Tunisia

  2019cites this paper
• Environmental risk assessment of widely used anticancer drugs (5-fluorouracil, cisplatin, etoposide, imatinib mesylate).

  2019cites this paper
• Coupling of nanofiltration and UV, UV/TiO2 and UV/H2O2 processes for the removal of anti-cancer drugs from real secondary wastewater effluent

  2019cites this paper
• 5-Fluorouracil—Complete Insight into Its Neutral and Ionised Forms

  2019cites this paper
• Protective Effect of Alpha Lipoic Acid and Royal Jelly against the Side Effects of Cyclophosphamide in Testis of Male Albino Rats

  2019cites this paper
• Monitoring hospital wastewaters for their probable genotoxicity.

  2019cites this paper
• Composition and production rate of cytostatic pharmaceutical waste from a Greek Cancer Treatment Hospital

  2019cites this paper
• In vitro and in vivo antitumor potential of carvacrol nanoemulsion against human lung adenocarcinoma A549 cells via mitochondrial mediated apoptosis

  2018cites this paper
• Toxicity and Biodegradation Testing

  2018influential citation
• A case study to identify priority cytostatic contaminants in hospital effluents.

  2018cites this paper
• Distribution of Anticancer Drugs in River Waters and Sediments of the Yodo River Basin, Japan

  2018cites this paper
• Improved Model for Biodegradability of Organic Compounds: The Correlation Contributions of Rings

  2018cites this paper
• Environmental risk assessment of platinum cytotoxic drugs: a focus on toxicity characterization of hospital effluents

  2018influential citation
• Occupational exposure to cytotoxic drugs: the importance of surface cleaning to prevent or minimise exposure

  2018cites this paper
• Evaluation of genotoxic potential of tert-butylquinone and its derivatives in prokaryotic and eukaryotic test models

  2018cites this paper
• Toxicogenomic responses of low level anticancer drug exposures in Daphnia magna.

  2018cites this paper
• Cytostatic drug removal using electrochemical oxidation with BDD electrode: Degradation pathway and toxicity.

  2018cites this paper
• Ecotoxicity of disinfectant benzalkonium chloride and its mixture with antineoplastic drug 5-fluorouracil towards alga Pseudokirchneriella subcapitata

  2018cites this paper
• Genotoxicity assessment of a selected cytostatic drug mixture in human lymphocytes: A study based on concentrations relevant for occupational exposure

  2018cites this paper
• A simultaneous determination of anti-cancer drugs in hospital effluent by DLLME HPLC-FLD, together with a risk assessment.

  2018cites this paper
• Cytotoxicity and genotoxicity of anticancer drug residues and their mixtures in experimental model with zebrafish liver cells.

  2017cites this paper
• Forgotten public health impacts of cancer – an overview

  2017cites this paper
• Assessment of the genotoxicity of the tyrosine kinase inhibitor imatinib mesylate in cultured fish and human cells.

  2017cites this paper
• Hazard screening of photo-transformation products from pharmaceuticals: Application to selective β1-blockers atenolol and metoprolol.

  2017cites this paper
• Association of GSTT1 null, XPD 751 CC and XPC 939 CC genotypes with increased levels of genomic damage among hospital pathologists

  2017influential citation
• Removal of cytostatic drugs by AOPs: A review of applied processes in the context of green technology

  2017cites this paper
• Composition and quantity of cytotoxic waste from oncology wards: A survey of environmental characterization and source management of medical cytotoxic waste

  2017cites this paper
• Application of titanium dioxide nanoparticles as a photocatalyst for the removal of micropollutants such as pharmaceuticals from water

  2017cites this paper
• Optimization and application of fabric phase sorptive extraction coupled to ultra-high performance liquid chromatography tandem mass spectrometry for the determination of cytostatic drug residues in environmental waters.

  2017cites this paper
• Evaluation of baseline frequency of sister chromatid exchanges in an Italian population according to age, sex, smoking habits, and gene polymorphisms

  2017cites this paper
• Distribution of six anticancer drugs and a variety of other pharmaceuticals, and their sorption onto sediments, in an urban Japanese river

  2017cites this paper
• Photo-Fenton and Fenton-like processes for the treatment of the antineoplastic drug 5-fluorouracil under simulated solar radiation

  2017cites this paper
• Suspect screening of micropollutants and their transformation products in advanced wastewater treatment.

  2017cites this paper
• Transformation products in the water cycle and the unsolved problem of their proactive assessment: A combined in vitro/in silico approach.

  2017cites this paper
• Biotransformation of amine-containing micropollutants in activated sludge PH-dependency and biotransformation reactions

  2016cites this paper
• Ecotoxic pharmaceuticals, personal care products, and other emerging contaminants: A review of environmental, receptor-mediated, developmental, and epigenetic toxicity with discussion of proposed toxicity to humans

  2016influential citation
• Genotoxic potential of selected cytostatic drugs in human and zebrafish cells

  2016cites this paper
• Detection of pharmaceuticals and phytochemicals together with their metabolites in hospital effluents in Japan, and their contribution to sewage treatment plant influents.

  2016cites this paper
• Combined cyto/genotoxic activity of a selected antineoplastic drug mixture in human circulating blood cells.

  2016cites this paper
• Chemical and toxicological characterisation of anticancer drugs in hospital and municipal wastewaters from Slovenia and Spain.

  2016cites this paper
• Systematic Exploration of Biotransformation Reactions of Amine-Containing Micropollutants in Activated Sludge.

  2016cites this paper
• Initial hazard screening for genotoxicity of photo-transformation products of ciprofloxacin by applying a combination of experimental and in-silico testing.

  2016cites this paper
• The leaching behavior of cyclophosphamide and ifosfamide from soil in the presence of co-contaminant--Mixture sorption approach.

  2016cites this paper
• Improving degradation of paracetamol by integrating gamma radiation and Fenton processes

  2016cites this paper
• Toxic effects of cisplatin cytostatic drug in mussel Mytilus galloprovincialis.

  2016cites this paper
• Ecotoxicity and genotoxicity of cyclophosphamide, ifosfamide, their metabolites/transformation products and their mixtures.

  2016cites this paper